Amplyx Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Amplyx Pharmaceuticals's estimated annual revenue is currently $1.1M per year.
- Amplyx Pharmaceuticals's estimated revenue per employee is $100,500
- Amplyx Pharmaceuticals's total funding is $198.4M.
Employee Data
- Amplyx Pharmaceuticals has 11 Employees.
- Amplyx Pharmaceuticals grew their employee count by 22% last year.
Amplyx Pharmaceuticals's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP | Reveal Email/Phone |
2 | CFO | Reveal Email/Phone |
3 | SVP, Regulatory Affairs | Reveal Email/Phone |
4 | VP, Clinical Operations | Reveal Email/Phone |
5 | SVP Development | Reveal Email/Phone |
6 | Senior Director Clinical Operations | Reveal Email/Phone |
7 | Chief Scientific Officer | Reveal Email/Phone |
8 | chief operating officer | Reveal Email/Phone |
9 | senior vice president, clinical development | Reveal Email/Phone |
Amplyx Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $84.8M | 422 | 24% | N/A | N/A |
#2 | $0.4M | 2 | 0% | N/A | N/A |
#3 | $32M | 159 | 3% | N/A | N/A |
#4 | $35M | 121 | 3% | $62.5M | N/A |
#5 | $30.2M | 150 | 18% | N/A | N/A |
#6 | $135.3M | 673 | 0% | N/A | N/A |
#7 | $110.3M | 549 | N/A | N/A | N/A |
#8 | $60.1M | 299 | -4% | N/A | N/A |
#9 | $554.8M | 1725 | 2% | N/A | N/A |
#10 | $10.5M | 52 | 4% | N/A | N/A |
What Is Amplyx Pharmaceuticals?
Amplyx was founded on a mission to save lives by developing a new class of antifungal medicine that would overcome the severe limitations of today's therapeutic options. We are developing first-in-class products for the treatment of life-threatening infections, with a near-term focus on deadly fungal pathogens in vulnerable, immune-compromised patients. Amplyx's leadership has extensive experience developing drugs to treat infectious diseases, as well as treatments for rare conditions. For more information on Amplyx, please visit our website at www.amplyx.com
keywords:N/A
$198.4M
Total Funding
11
Number of Employees
$1.1M
Revenue (est)
22%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Amplyx Pharmaceuticals News
But Utah-based Sorriso Pharmaceuticals is looking to calm these immune systems ... was in her leadership roles at Amplyx Pharmaceuticals,...
... which brought aboard the drug (originated by Novartis AG) by way of the buyout of Amplyx Pharmaceuticals Inc. in April 2021.
... from Amplyx Pharmaceuticals, Inc., a wholly owned subsidiary of ... Ms. Hall is a pharmaceutical industry leader who brings more than 30...
SAN DIEGO, Dec. 3, 2020 /PRNewswire/ -- Amplyx Pharmaceuticals, a clinical-stage biopharmaceutical company developing innovative therapies for debilitating and life-threatening diseases in patients with compromised immune systems, announced today that clinical and preclinical data for its Phas ...
Other Companies in San Diego
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.9M | 11 | -39% | $126.6M |
#2 | $1M | 11 | N/A | N/A |
#3 | $1M | 11 | N/A | N/A |
#4 | $1M | 11 | N/A | N/A |
#5 | $1M | 11 | N/A | N/A |